NFKB1 and cancer: Initially, the inhibition of NF-κB signaling was considered to be the primary mechanism underlying the anti-cancer effects of PIs, as this pathway is involved in critical cellular processes such as cell proliferation, invasion, metastasis, and angiogenesis.